Teeing up for success.
Keep your cell therapy quality goals on course.
For cell therapy manufacturers, developing and implementing robust and reproducible workflows is critical to produce safe and effective therapies.
Due to their impact on the safety, purity, and potency of the final therapeutic, raw materials—such as cell culture media, supplements, growth factors, and cell separation reagents—play a key role in helping manufacturers achieve this. Moreover, to keep development timelines on track, the chosen raw materials must meet the criteria for regulatory approval when transitioning to commercial production.
In this article, we share insights to help you successfully navigate the complexity of raw material selection. This includes providing an overview of the latest raw material regulatory guidance, as well as exploring how a trusted supplier can provide support to help streamline the regulatory filing process.
Discover the importance of taking a proactive approach to raw material selection and find out how choosing CGMP-manufactured solutions at the earliest stage can provide significant long-term benefits.
To learn more about how you can unlock your edge in cell therapy, visit: thermofisher.com/performance
